Market Cap 2.96M
Revenue (ttm) 0.00
Net Income (ttm) -7.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 14,600
Avg Vol 49,708
Day's Range N/A - N/A
Shares Out 5.48M
Stochastic %K 58%
Beta 0.47
Analysts Hold
Price Target $12.00

Company Profile

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 693 8448
Fax: 972 3 693 8447
Address:
16 Abba Hillel Road, Ramat Gan, Israel
madan_shatri
madan_shatri Apr. 4 at 4:43 AM
$GLMD Creep back to $0.80s range in next couple of weeks then a solid PR/Update could send this to $1.50+ easily
1 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 3 at 8:50 PM
$GLMD "it’s ridiculously undervalued" https://x.com/ej23ny/status/2039085450372043115
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 3 at 8:48 PM
$GLMD Oncology applications: “Our data demonstrates that UM cells are killed by treatment with aramchol plus regorafenib plus metformin via enhanced autophagic flux and that this combination may have the potential to control UM tumors that have metastasized to the liver.” https://www.eurekalert.org/news-releases/1122180
2 · Reply
never_chase
never_chase Apr. 2 at 8:04 PM
$GLMD still holding
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 2 at 6:18 PM
0 · Reply
Mile111
Mile111 Apr. 2 at 3:33 PM
$GLMD feuer
0 · Reply
Lowlyme
Lowlyme Apr. 2 at 2:05 AM
$GLMD Allen's salary approximately 1.2 million a year. 1.2 million x 25 years would be.... CEOs take so far. No bad.
0 · Reply
Lowlyme
Lowlyme Apr. 2 at 2:01 AM
$GLMD Galmed has been around for almost a quarter of a century now and here we are?
0 · Reply
madan_shatri
madan_shatri Apr. 1 at 9:07 PM
$GLMD today ::
2 · Reply
Mile111
Mile111 Apr. 1 at 8:28 PM
0 · Reply
Latest News on GLMD
Galmed Issues CEO Letter to Shareholders

Dec 1, 2025, 8:30 AM EST - 4 months ago

Galmed Issues CEO Letter to Shareholders


madan_shatri
madan_shatri Apr. 4 at 4:43 AM
$GLMD Creep back to $0.80s range in next couple of weeks then a solid PR/Update could send this to $1.50+ easily
1 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 3 at 8:50 PM
$GLMD "it’s ridiculously undervalued" https://x.com/ej23ny/status/2039085450372043115
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 3 at 8:48 PM
$GLMD Oncology applications: “Our data demonstrates that UM cells are killed by treatment with aramchol plus regorafenib plus metformin via enhanced autophagic flux and that this combination may have the potential to control UM tumors that have metastasized to the liver.” https://www.eurekalert.org/news-releases/1122180
2 · Reply
never_chase
never_chase Apr. 2 at 8:04 PM
$GLMD still holding
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 2 at 6:18 PM
0 · Reply
Mile111
Mile111 Apr. 2 at 3:33 PM
$GLMD feuer
0 · Reply
Lowlyme
Lowlyme Apr. 2 at 2:05 AM
$GLMD Allen's salary approximately 1.2 million a year. 1.2 million x 25 years would be.... CEOs take so far. No bad.
0 · Reply
Lowlyme
Lowlyme Apr. 2 at 2:01 AM
$GLMD Galmed has been around for almost a quarter of a century now and here we are?
0 · Reply
madan_shatri
madan_shatri Apr. 1 at 9:07 PM
$GLMD today ::
2 · Reply
Mile111
Mile111 Apr. 1 at 8:28 PM
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 1 at 1:14 PM
$GLMD Of today's premarket volume of 2027 shares, 2025 were at 0.529. Only 2 at 0.4751.
1 · Reply
madan_shatri
madan_shatri Apr. 1 at 2:48 AM
$GLMD Yesterday ::
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 1 at 12:02 AM
$GLMD That SEC Form POS AM... get ready for the pump.
1 · Reply
BankOnTheFuture
BankOnTheFuture Mar. 31 at 11:55 PM
$GLMD From today's Form 20-F: "As of December 31, 2025, we had a net working capital of $15.8 million, cash and cash equivalents of $4.0 million, restricted cash of $0.1 million, short term deposits of $7.1 million and marketable debt securities of $7.0 million. Based on our current operating plan, we currently estimate that our cash position will support our current operations as currently conducted for more than 12 months from the date of issuance of this annual report."
0 · Reply
getsometoday
getsometoday Mar. 31 at 9:18 PM
$GLMD how much cash they have on hand
0 · Reply
Shakattack31
Shakattack31 Mar. 31 at 8:39 PM
$GLMD pr is out
0 · Reply
BankOnTheFuture
BankOnTheFuture Mar. 31 at 8:17 PM
$GLMD wonder if they get awarded an FDA National Priority Voucher for Aramchol?
1 · Reply
Shakattack31
Shakattack31 Mar. 31 at 7:41 PM
$GLMD tomorrow supposed to be the ER , you can never know 🚀⚡️
0 · Reply
Mile111
Mile111 Mar. 31 at 7:37 PM
0 · Reply
big_bosss
big_bosss Mar. 31 at 7:23 PM
$GLMD tbh i think the execution on trials matters most but until we see updates its fair to stay cautious
0 · Reply
BearTamerTrading
BearTamerTrading Mar. 30 at 10:58 PM
We also got $ANNA $JCSE $SGML $GLMD $QNTM and a few others as well. Congratulations to all members and other retail traders that joined the free live trading session, the stream will be free all week. Here are more of our peers securing gains ! Click on the link for the replay (proof of alerts) 👇🏾 https://www.youtube.com/live/HeE3cBLrLBo?si=904uAF3yQikiTtX5
3 · Reply
madan_shatri
madan_shatri Mar. 30 at 3:03 PM
$GLMD Its over guys.I am keep saying, everything is completely irrelevant. If no external money, then whoever has bought above $0.70 won't see his/her money back. Its basically over. Had this is a really good stock, it would've never down to such a low level. Don't make fool of self, its not MM, instead, its worth is even lower than where it is trading today
1 · Reply